Central Nervous System Toxoplasmosis in the Setting of Mycophenolate Mofetil Monotherapy for Autoimmune Hepatitis
Central nervous system (CNS) toxoplasmosis is a life-threatening opportunistic infection most often reported in patients with HIV/AIDS and solid organ transplantation. Its occurrence in immunocompetent patients is rare and even less commonly reported in those receiving single-agent immunosuppressive...
Saved in:
| Main Authors: | Sathish Krishnan MD, FCCP, Vijaya Sivalingam Ramalingam MD, FCCP, Anam Naumaan MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-08-01
|
| Series: | Journal of Investigative Medicine High Impact Case Reports |
| Online Access: | https://doi.org/10.1177/23247096251366928 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Should mycophenolate mofetil be first-line treatment in autoimmune hepatitis?
by: J.A. Torres-Díaz, et al.
Published: (2025-04-01) -
Sarcoidosis Presenting as a Giant Pulmonary Bulla With Concurrent COVID-19 Infection
by: Sathish Krishnan MD, FCCP, et al.
Published: (2025-05-01) -
Favorable long-term outcomes of autoimmune nodopathy with mycophenolate mofetil
by: Young Gi Min, et al.
Published: (2024-12-01) -
Mycophenolate mofetil and atherosclerosis
by: Z S Alekberova, et al.
Published: (2009-10-01) -
Indications and Long-Term Outcomes of Using Mycophenolate Mofetil Monotherapy in Substitution for Calcineurin Inhibitors in Liver Transplantation
by: Carlos Jiménez-Romero, et al.
Published: (2025-02-01)